Multiple Trauma/Injuries — A Multicenter, Randomized Study of Early Assessment by CT Scanning in Severely Injured Trauma Patients
Citation(s)
Albrecht T, von Schlippenbach J, Stahel PF, Ertel W, Wolf KJ [The role of whole body spiral CT in the primary work-up of polytrauma patients--comparison with conventional radiography and abdominal sonography]. Rofo. 2004 Aug;176(8):1142-50. German.
Fanucci E, Fiaschetti V, Rotili A, Floris R, Simonetti G Whole body 16-row multislice CT in emergency room: effects of different protocols on scanning time, image quality and radiation exposure. Emerg Radiol. 2007 Feb;13(5):251-7. Epub 2006 Dec 20.
Maurer MH, Knopke S, Schröder RJ [Added diagnostic benefit of 16-row whole-body spiral CT in patients with multiple trauma differentiated by region and injury severity according to the ATLS concept]. Rofo. 2008 Dec;180(12):1117-23. doi: 10.1055/s-2008-1027851. Epub 2008 Nov 28. German.
Philipp MO, Kubin K, Hörmann M, Metz VM Radiological emergency room management with emphasis on multidetector-row CT. Eur J Radiol. 2003 Oct;48(1):2-4. Review.
Ptak T, Rhea JT, Novelline RA Radiation dose is reduced with a single-pass whole-body multi-detector row CT trauma protocol compared with a conventional segmented method: initial experience. Radiology. 2003 Dec;229(3):902-5.
Rieger M, Czermak B, El Attal R, Sumann G, Jaschke W, Freund M Initial clinical experience with a 64-MDCT whole-body scanner in an emergency department: better time management and diagnostic quality? J Trauma. 2009 Mar;66(3):648-57. doi: 10.1097/TA.0b013e31816275f3.
Smith CM, Woolrich-Burt L, Wellings R, Costa ML Major trauma CT scanning: the experience of a regional trauma centre in the UK. Emerg Med J. 2011 May;28(5):378-82. doi: 10.1136/emj.2009.076414. Epub 2010 Jun 1.
World Health Organization The global burden of disease: 2004 update. [http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html]
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.